CYTOKINETICS, INCORPORATED Loss Contingency Accrual, Provision
CYTOKINETICS, INCORPORATED (CYTK) reported Loss Contingency Accrual, Provision of $0 for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-05.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LossContingencyAccrualProvision · last filed 2016-05-05
- CYTOKINETICS, INCORPORATED loss contingency accrual, provision for the quarter ending 2016-03-31 was $0.00.
- CYTOKINETICS, INCORPORATED loss contingency accrual, provision for the quarter ending 2015-12-31 was $0.00.
- CYTOKINETICS, INCORPORATED loss contingency accrual, provision for the quarter ending 2015-09-30 was $0.00.
- CYTOKINETICS, INCORPORATED loss contingency accrual, provision for the quarter ending 2015-06-30 was $0.00.
- CYTOKINETICS, INCORPORATED loss contingency accrual, provision for fiscal 2015 was $0.00.
| Period end | Loss Contingency Accrual, Provision 3 month | Loss Contingency Accrual, Provision 6 month | Loss Contingency Accrual, Provision 9 month | Loss Contingency Accrual, Provision 12 month |
|---|---|---|---|---|
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2016-05-05 | $0.00 derived: sum of 3 quarters · filed 2016-05-05 | $0.00 derived: sum of 4 quarters · filed 2016-05-05 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $0.00 derived: sum of 2 quarters · filed 2016-03-03 | $0.00 derived: sum of 3 quarters · filed 2016-03-03 | $0.00 10-K · filed 2016-03-03 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $0.00 10-Q · filed 2015-08-05 | ||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |